4
Changes in Ownership
Oncotelic Therapeutics, Inc. Filed Acc 0001209191-18-024991
Director bought 250,000 shares
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Reynolds Donald Rogers Director | 2018-04-12 | Purchase | +250,000 | 280,000 | D | ||
| Derivatives | |||||||
| Reynolds Donald Rogers Director | 2018-04-12 | Purchase · Common Stock A Warrants (Right to Buy) | +125,000 | 125,000 | D | ||
| Reynolds Donald Rogers Director | 2018-04-12 | Purchase · Common Stock B Warrants (Right to Buy) | +125,000 | 125,000 | D | ||
| Open-market purchases · 250,000 sh | |||||||
Loading xslF345X03/doc4.xml…